TB-500, a synthetic analog of thymosin beta-4, has demonstrated benefits in modulating actin dynamics, improving cell migration, and promoting angiogenesis
Beyond 500mcg, the risk-benefit ratio becomes less favorable
Regenerative Focus: While conventional treatments often manage symptoms, exosomes aim to repair and rejuvenate reproductive tissues at the source
Unfortunately, many of us don't get enough of this critical molecule in our diets
IV administration also introduces risks that oral supplementation does not: Contamination or excessive endotoxin exposure Sterility and compounding failures Infusion reactions Venous irritation or infection Dosing errors Additional cost and clinical complexity The FDA has reported adverse events among patients who received injectable compounded glutathione made with an unsuitable dietary ingredient
[1] Examples involve D-peptide and peptidic foldamers such as beta-peptides